Continental Pharma Resources
Finance & Banking · Lobbying Client
C
Influence Score
47/100
Moderate Influence
$1.9M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Continental Pharma Resources reported $1.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Banking, Financial Institutions, Taxation. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Federal Energy Regulatory Commission
Dept of Energy
Food & Drug Administration
Small Business Administration
Dept of Defense
Dept of Housing & Urban Development
Dept of Treasury
Federal Communications Commission
Office of Management & Budget
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Cassidy & Associates LLP | FINGOVGAM | 1 | $102K |
| 2020 Apr-Jun | Cassidy & Associates LLP | GAMBANFIN+1 | 1 | $131K |
| 2020 Jul-Sep | Brownstein Hyatt LLP | GOVCPT | 1 | $73K |
| 2020 Oct-Dec | Akin Gump LLP | GAM | 1 | $102K |
| 2021 Jan-Mar | K&L Gates LLP | GAMFINCPT+2 | 1 | $77K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | FINBAN | 1 | $79K |
| 2021 Jul-Sep | Holland & Knight LLP | GOVCPTBAN | 1 | $78K |
| 2021 Oct-Dec | Brownstein Hyatt LLP | BANCPTFIN+1 | 1 | $87K |